Medtronic Cardiac Rhythm And Heart Failure
Clinical trials sponsored by Medtronic Cardiac Rhythm And Heart Failure, explained in plain language.
A division of Medtronic focused on cardiac rhythm management and heart failure devices.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
Tiny heart pump trial halted early – what went wrong?
Disease control TerminatedThis study tested a small, implantable heart pump called the HeartWare MVAD in 11 people with advanced heart failure. The goal was to see if the device could safely help the heart pump blood. However, the trial was stopped early, so we have limited information on how well it work…
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Heart device study in india aims to track AF progression
Knowledge-focused TerminatedThis study looked at how Medtronic heart devices detect and manage atrial fibrillation (AF) in Indian patients. It tracked whether the condition became persistent over time. The study enrolled 79 people over 55 with heart devices. It was terminated early, so results are limited.
Phase: NA • Sponsor: Medtronic Cardiac Rhythm and Heart Failure • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:08 UTC